• US: +1 9176726599
  • Login

Global Life Science Products Market to Record Protruding Growth With US$ 46,704.8 Million By 2027

Published date - 17/04/2022

April 2021 | Report Format: Electronic (PDF)

Increased investment in the biosciences industry is likely to drive development in the worldwide bioscience goods industry during the projected timeframe. For example, Purdue-affiliated Amplify Biosciences LLC and Brightlamp Inc. both got a US$ 250,000 award from the Yale Forge Investment Account in Feb 2020 towards Research & development activities in bioscience innovations.

Furthermore, R&D in unusual illnesses is projected to contribute to industry expansion. For example, Oraxion Pharmaceuticals, Inc., a company of India-based Aten Semi-permeable, is doing preliminary and effective research on the medication ORX-301, that might be utilized to cure FSGS. Oraxion Therapeutics, Inc. agreed under an Agreement Signed with a biotech firm headquartered in the United States in March 2018. The deal grants the U.S.-based business exclusive access to continue medical investigations as well as the licensing of ORX-301 inside the United States.

The industry in the Asia Pacific is expected to dominate during the projected timeframe, due to the increasing presence of top companies in rising Asian nations and expenditures in the development of improved screening procedures. Because experienced personnel is available at a lesser price in the Asia Pacific compared in industrialized nations in Europe And japan, the area is an attractive location for outsourced biopharmaceutical Research and innovation As a result of profitable prospects in various Asian nations, international CROs has extended business footprint in the Asia Pacific region.

Request a Free Sample Copy: Life Science Products Market Report

Life Science Products Market Report Highlights

  • For example, at the SRNT Yearly Conference in New Orleans in April 2020, Achieve Life Sciences, Inc., a diagnostic drug manufacturer, proffered quantitatively assess assessments from of the ORCA-1 Step 2b test which evaluated the efficacy of 'Cytisinicline,' an organic isoquinoline with such a strong affinity fondness to the 42 nicotine binding site.
  • For example, Thermo Fisher Scientific Inc. initiated the Cytomat 2 C-LiN Series “ automatic Incubator in Oct. 2019, which also is intended to provide cellular proliferation and pollution monitoring along with a variety of microtiter plate uses such as cell-based testing, induced immune tests, bacteriology, as well as enzyme trialing.

 

LIFE SCIENCE PRODUCTS MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Life Science Products Market Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Recombinant Proteins
    • Immune Checkpoint Regulators
    • Chemokines
    • Growth Factors
    • Cytokines
    • Colony Stimulating Factors
    • Hormones
    • Enzymes & Inhibitors
    • Others
  • Cell Lines
    • Immunotherapy Cell Lines
    • Ion Channel Cell Lines
    • GPCR Cell Lines
    • Cell Signaling Pathway Cell Lines
    • Gene Knockout Cell Lines
    • Cancer Cell Lines
    • Others
  • Antibodies
    • Immune Checkpoint Antibodies
    • Epitope Tag Antibodies
    • Isotype Control Antibodies
      • Research Use
      • In-vivo Grade
    • Primary Antibodies
      • Research Use
      • In-vivo Grade
  • Assay Antibodies (includes secondary antibodies)
  • Others
    • Viable Tumor Samples
    • Tumor Tissue Microarrays

Life Science Products Market Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Drug Discovery & Development
  • Tissue Engineering
  • Drug Screening
  • Toxicity Screening
  • Basic Research
  • Biopharmaceutical Production
  • Forensic Testing

Life Science Products Market End User Outlook (Revenue, USD Million, 2016 - 2027)

  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Forensic Science Laboratories
  • Diagnostic Centers
  • Others

Life Science Products Market Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players- Life Science Products Market

  • A.M.S. Biotechnology (Europe) Limited
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • BPS Bioscience Inc.
  • Bruker
  • Crown Bioscience Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Genscript Biotech Corporation
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN
  • Shimadzu Corporation
  • Sigma Aldrich Corp.
  • Thermo Fisher Scientific Inc.
  • Zeiss International

 

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/

Copyright © 2022 Market Research Strategy, All rights reserved.